REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Conclisan CIA Ltda (Ecuador)

Main Activities: Psychiatric and Substance Abuse Hospitals
Full name: Conclisan CIA Ltda Profile Updated: April 06, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Hospital General Privado provides specialized medical care in Clinical Oncology, General Medicine, Geriatria, General Surgery, Intensive Care Unit, and Digestive Surgery. The company's target market is patients in need of medical care.

Headquarters
Quito 118, Clinica Santiago Bldg.
Santo Domingo; Santo Domingo de los Tsachilas;

Contact Details: Purchase the Conclisan CIA Ltda report to view the information.

Website: http://www.clinicasantiago.com.ec

Basic Information
Total Employees:
Purchase the Conclisan CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Conclisan CIA Ltda report to view the information.
Registered Capital:
Purchase the Conclisan CIA Ltda report to view the information.
Incorporation Date:
August 17, 2011
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
35.82%
Purchase this report to view the information.
19.02%
Purchase this report to view the information.
6.48%
Purchase this report to view the information.
6.48%
Purchase this report to view the information.
6.48%
Company Performance
Financial values in the chart are available after Conclisan CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
4.83%▲
Total operating revenue
4.13%▲
Operating profit (EBIT)
-51.53%▼
EBITDA
-39.68%▼
Net Profit (Loss) for the Period
-58.43%▼
Total assets
1.62%▲
Total equity
-18.85%▼
Operating Profit Margin (ROS)
-5.32%▼
Net Profit Margin
-3.22%▼
Return on Equity (ROE)
-15.61%▼
Debt to Equity Ratio
6.15%▲
Quick Ratio
-0.01%▼
Cash Ratio
-0.2%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo